Ad is loading...
JGLYX
Price
$19.12
Change
+$0.35 (+1.86%)
Updated
Nov 21 closing price
VSGAX
Price
$102.83
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

JGLYX vs VSGAX

Header iconJGLYX vs VSGAX Comparison
Open Charts JGLYX vs VSGAXBanner chart's image
JPMorgan Small Cap Growth R4
Price$19.12
Change+$0.35 (+1.86%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index Admiral
Price$102.83
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JGLYX vs VSGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGLYX vs. VSGAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGLYX is a Buy and VSGAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 35.8B vs. JGLYX (3.75B). VSGAX pays higher dividends than JGLYX: VSGAX (0.66) vs JGLYX (0.00). JGLYX was incepted earlier than VSGAX: JGLYX (7 years) vs VSGAX (13 years). JGLYX is a more actively managed with annual turnover of: 33.00 vs. VSGAX (19.00). JGLYX has a lower initial minimum investment than VSGAX: JGLYX (0) vs VSGAX (3000). VSGAX annual gain was more profitable for investors over the last year : 35.72 vs. JGLYX (33.33). VSGAX return over 5 years is better than : 53.72 vs. JGLYX (7.51).
JGLYXVSGAXJGLYX / VSGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years13 years-
Gain YTD18.61021.27287%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.75B35.8B10%
Annual Yield % from dividends0.000.66-
Returns for 1 year33.3335.7293%
Returns for 3 years-24.191.64-1,471%
Returns for 5 years7.5153.7214%
Returns for 10 yearsN/A137.60-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
Z82.154.27
+5.48%
Zillow Group
CVBF23.190.62
+2.75%
CVB Financial Corp
BRY4.260.07
+1.67%
Berry Corp
EVOK4.50-0.06
-1.32%
Evoke Pharma, Inc.
CXDO5.03-0.14
-2.71%
Crexendo